Source
Neurology
Abstract
Objective
To assess the neuropathic burden and quality-of-life impact in patients with wild-type transthyretin amyloidosis (wtATTR) using standardized clinical and patient-reported outcomes.
Background
Wild-type transthyretin amyloidosis is increasingly diagnosed in older adults and is associated with systemic involvement, especially cardiomyopathy. However, the burden and phenotype of neuropathy in wtATTR remain poorly defined due to limited prospective data.
News Url